AMI ORGANICS
Quarterly Results Analysis [Mar2025]
AMI ORGANICS Quarterly Results
Consolidated | Mar2025 Audited |
Dec2024 Audited |
Sep2024 Audited |
Jun2024 Audited |
Mar2024 Audited |
Dec2023 Audited |
Sep2023 Audited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹308 Cr | ₹275 Cr | ₹247 Cr | ₹177 Cr | ₹225 Cr | ₹166 Cr | ₹172 Cr | ₹154 Cr |
Expenses | ₹224 Cr | ₹206 Cr | ₹198 Cr | ₹147 Cr | ₹182 Cr | ₹140 Cr | ₹148 Cr | ₹120 Cr |
Operating Income | ₹85 Cr | ₹69 Cr | ₹49 Cr | ₹30 Cr | ₹43 Cr | ₹27 Cr | ₹25 Cr | ₹34 Cr |
Other Income | ₹6 Cr | ₹2 Cr | ₹8 Cr | ₹1 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr |
Depreciation | ₹7 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹83 Cr | ₹63 Cr | ₹50 Cr | ₹20 Cr | ₹37 Cr | ₹24 Cr | ₹-10 Cr | ₹31 Cr |
Profit After Tax | ₹63 Cr | ₹45 Cr | ₹38 Cr | ₹15 Cr | ₹26 Cr | ₹18 Cr | ₹-17 Cr | ₹22 Cr |
EPS | ₹7.63 | ₹5.49 | ₹4.56 | ₹1.70 | ₹6.82 | ₹2.27 | ₹-2.56 | ₹2.71 |
Industry Peers & Returns | 1W | 1M | 1Y |
AMI ORGANICS | 0.1% | -7.6% | 92.6% |
SUN PHARMACEUTICAL INDUSTRIES | -3.4% | -0.2% | 18.1% |
DIVIS LABORATORIES | -2.3% | 3.4% | 55.5% |
CIPLA | -2.6% | -0.6% | 5.9% |
TORRENT PHARMACEUTICALS | -2.3% | -2.1% | 20.4% |
DR REDDYS LABORATORIES | -2.9% | -0.2% | -8.7% |
MANKIND PHARMA | 2.2% | 0.3% | 5% |
ZYDUS LIFESCIENCES | -1.5% | -3.2% | -11.1% |
LUPIN | -2.1% | -3.9% | 25.1% |
AMI ORGANICS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 12.18 % |
Y-o-Y | 37.13 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹308 Cr | 12.18 | |
Dec2024 | ₹275 Cr | 11.45 | |
Sep2024 | ₹247 Cr | 39.66 | |
Jun2024 | ₹177 Cr | -21.46 | |
Mar2024 | ₹225 Cr | 35.15 | |
Dec2023 | ₹166 Cr | -3.43 | |
Sep2023 | ₹172 Cr | 12.13 | |
Jun2023 | ₹154 Cr | - |
AMI ORGANICS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 23.72 % |
Y-o-Y | 96.85 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹85 Cr | 23.72 | |
Dec2024 | ₹69 Cr | 40.33 | |
Sep2024 | ₹49 Cr | 65.78 | |
Jun2024 | ₹30 Cr | -31.61 | |
Mar2024 | ₹43 Cr | 62.80 | |
Dec2023 | ₹27 Cr | 6.83 | |
Sep2023 | ₹25 Cr | -27.03 | |
Jun2023 | ₹34 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 10.29 % |
Y-o-Y | 43.51 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 27.54% | 10.29 | |
Dec2024 | 24.97% | 25.92 | |
Sep2024 | 19.83% | 18.67 | |
Jun2024 | 16.71% | -12.92 | |
Mar2024 | 19.19% | 20.46 | |
Dec2023 | 15.93% | 10.63 | |
Sep2023 | 14.4% | -34.90 | |
Jun2023 | 22.12% | - |
AMI ORGANICS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 38.01 % |
Y-o-Y | 144.24 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹63 Cr | 38.01 | |
Dec2024 | ₹45 Cr | 20.97 | |
Sep2024 | ₹38 Cr | 155.72 | |
Jun2024 | ₹15 Cr | -42.79 | |
Mar2024 | ₹26 Cr | 44.17 | |
Dec2023 | ₹18 Cr | Positive | |
Sep2023 | ₹-17 Cr | Negative | |
Jun2023 | ₹22 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 22.99 % |
Y-o-Y | 78.18 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 20.33 % | 22.99 | |
Dec2024 | 16.53 % | 8.54 | |
Sep2024 | 15.23 % | 83.27 | |
Jun2024 | 8.31 % | -27.17 | |
Mar2024 | 11.41 % | 6.64 | |
Dec2023 | 10.7 % | Positive | |
Sep2023 | -9.87 % | Negative | |
Jun2023 | 14.47 % | - |
AMI ORGANICS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 38.98 % |
Y-o-Y | 11.88 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹7.63 | 38.98 | |
Dec2024 | ₹5.49 | 20.39 | |
Sep2024 | ₹4.56 | 168.24 | |
Jun2024 | ₹1.7 | -75.07 | |
Mar2024 | ₹6.82 | 200.44 | |
Dec2023 | ₹2.27 | Positive | |
Sep2023 | ₹-2.56 | Negative | |
Jun2023 | ₹2.71 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD